Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy.

PaperCitations, authors & open-access status

Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 183 citations, 2003 year and closed oa status.